x

Search for a clinical trial

* (*) mandatory field

An early-phase, multicenter, open-label study of the safety and pharmacokinetics of anti-PD-L1 antibody (MPDL3280A) in pediatric and young adult patients with previously treated solid tumors (phase I-II) - AT

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Hoffmann - la roche ltd.
  • Website
    • Phase : I - II
  • Principal investigator of clinical trial

  • Pr Michael DWORZAK
  • Zentrum für Kinder- und Jugendheilkunde
  • St. Anna Kinderspital
  • Kinderspitalgasse 6
  • 1090 WIEN
  • AUSTRIA
  • More information
  • Phone  : +43 (0)1 40170
  • Fax  : -
  • Website
Last update: March 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.